Cancer Research Cancer Health Disparities Conference 2009 AM No Date
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suh, N.
Right arrow Articles by Sporn, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suh, N.
Right arrow Articles by Sporn, M. B.
[Cancer Research 63, 1371-1376, March 15, 2003]
© 2003 American Association for Cancer Research

Molecular Biology and Genetics

Synthetic Triterpenoids Enhance Transforming Growth Factor ß/Smad Signaling1

Nanjoo Suh, Anita B. Roberts, Stephanie Birkey Reffey, Kohei Miyazono, Susumu Itoh, Peter ten Dijke, Elke H. Heiss, Andrew E. Place, Renee Risingsong, Charlotte R. Williams, Tadashi Honda, Gordon W. Gribble and Michael B. Sporn2

Dartmouth Medical School and Dartmouth College, Hanover, New Hampshire 03755 [N. S., E. H. H., A. E. P., R. R., C. R. W., T. H., G. W. G., M. B. S.]; National Cancer Institute, NIH, Bethesda, Maryland 20892 [A. B. R., S. B. R.]; Cancer Institute, Tokyo 170-8455, Japan [K. M.]; and The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands [S. I., P. t. D.]

We have studied the effects of two new synthetic triterpenoids, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) and its derivative, 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole (CDDO-Im), on transforming growth factor (TGF)-ß/Smad signaling. These agents, at nanomolar concentrations, increase the expression of TGF-ß-dependent genes, such as those for plasminogen activator inhibitor 1 and the type II TGF-ß receptor, and they synergize with TGF-ß in this regard. They prolong the activation of Smad2 induced by TGF-ß and markedly enhance the ability of Smad3 to activate a Smad binding element, CAGA-luciferase. In transfection assays, they reverse the inhibitory effects of Smad7. CDDO and CDDO-Im also enhance Smad signaling in the pathways of two other members of the TGF-ß superfamily, namely, activin and bone morphogenetic protein. Finally, these triterpenoids induce expression of the transcriptional coactivator p300-CBP-associated factor and synergize with TGF-ß in this regard. These are the first studies to report enhancement of Smad signaling by synthetic triterpenoids and should further their optimal use for applications in prevention or treatment of diseases in which there is aberrant function of TGF-ß.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
C. To, S. Kulkarni, T. Pawson, T. Honda, G. W. Gribble, M. B. Sporn, J. L. Wrana, and G. M. Di Guglielmo
The Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid-Imidazolide Alters Transforming Growth Factor {beta}-dependent Signaling and Cell Migration by Affecting the Cytoskeleton and the Polarity Complex
J. Biol. Chem., April 25, 2008; 283(17): 11700 - 11713.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
N. Vannini, G. Lorusso, R. Cammarota, M. Barberis, D. M. Noonan, M. B. Sporn, and A. Albini
The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent
Mol. Cancer Ther., December 1, 2007; 6(12): 3139 - 3146.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Koschmieder, F. D'Alo, H. Radomska, C. Schoneich, J. S. Chang, M. Konopleva, S. Kobayashi, E. Levantini, N. Suh, A. Di Ruscio, et al.
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha
Blood, November 15, 2007; 110(10): 3695 - 3705.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. M. Yore, K. T. Liby, T. Honda, G. W. Gribble, and M. B. Sporn
The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-{kappa}B activation through direct inhibition of I{kappa}B kinase {beta}
Mol. Cancer Ther., December 1, 2006; 5(12): 3232 - 3239.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Liby, N. Voong, C. R. Williams, R. Risingsong, D. B. Royce, T. Honda, G. W. Gribble, M. B. Sporn, and J. J. Letterio
The Synthetic Triterpenoid CDDO-Imidazolide Suppresses STAT Phosphorylation and Induces Apoptosis in Myeloma and Lung Cancer Cells.
Clin. Cancer Res., July 15, 2006; 12(14): 4288 - 4293.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Ji, H. J. Lee, C. Goodman, M. Uskokovic, K. Liby, M. Sporn, and N. Suh
The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells.
Mol. Cancer Ther., June 1, 2006; 5(6): 1452 - 1458.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H. J. Lee, A. Wislocki, C. Goodman, Y. Ji, R. Ge, H. Maehr, M. Uskokovic, M. Reiss, and N. Suh
A Novel Vitamin D Derivative Activates Bone Morphogenetic Protein Signaling in MCF10 Breast Epithelial Cells
Mol. Pharmacol., June 1, 2006; 69(6): 1840 - 1848.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H.-J. Park, E. Partridge, P. Cheung, J. Pawling, R. Donovan, J. L. Wrana, and J. W. Dennis
Chemical Enhancers of Cytokine Signaling that Suppress Microfilament Turnover and Tumor Cell Growth.
Cancer Res., April 1, 2006; 66(7): 3558 - 3566.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Shishodia, G. Sethi, M. Konopleva, M. Andreeff, and B. B. Aggarwal
A Synthetic Triterpenoid, CDDO-Me, Inhibits I{kappa}B{alpha} Kinase and Enhances Apoptosis Induced by TNF and Chemotherapeutic Agents through Down-Regulation of Expression of Nuclear Factor {kappa}B-Regulated Gene Products in Human Leukemic Cells
Clin. Cancer Res., March 15, 2006; 12(6): 1828 - 1838.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. D. Westerheide, J. D. Bosman, B. N. A. Mbadugha, T. L. A. Kawahara, G. Matsumoto, S. Kim, W. Gu, J. P. Devlin, R. B. Silverman, and R. I. Morimoto
Celastrols as Inducers of the Heat Shock Response and Cytoprotection
J. Biol. Chem., December 31, 2004; 279(53): 56053 - 56060.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. S. Oh, A. Moharita, J. G. Potian, I. P. Whitehead, J. C. Livingston, T. A. Castro, P. S. Patel, and P. Rameshwar
Bone Marrow Stroma Influences Transforming Growth Factor-{beta} Production in Breast Cancer Cells to Regulate c-myc Activation of the Preprotachykinin-I Gene in Breast Cancer Cells
Cancer Res., September 1, 2004; 64(17): 6327 - 6336.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. H. Rendi, N. Suh, W. W. Lamph, S. Krajewski, J. C. Reed, R. A. Heyman, A. Berchuck, K. Liby, R. Risingsong, D. B. Royce, et al.
The Selective Estrogen Receptor Modulator Arzoxifene and the Rexinoid LG100268 Cooperate to Promote Transforming Growth Factor {beta}-Dependent Apoptosis in Breast Cancer
Cancer Res., May 15, 2004; 64(10): 3566 - 3571.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. S. Mix, C. I. Coon, E. D. Rosen, N. Suh, M. B. Sporn, and C. E. Brinckerhoff
Peroxisome Proliferator-Activated Receptor-{gamma}-Independent Repression of Collagenase Gene Expression by 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid and Prostaglandin 15-Deoxy-{Delta}(12,14) J2: A Role for Smad Signaling
Mol. Pharmacol., February 1, 2004; 65(2): 309 - 318.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. L. Sabichi, M.-F. Demierre, E. T. Hawk, C. E. Lerman, and S. M. Lippman
Frontiers in Cancer Prevention Research
Cancer Res., September 15, 2003; 63(18): 5649 - 5655.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. E. Place, N. Suh, C. R. Williams, R. Risingsong, T. Honda, Y. Honda, G. W. Gribble, L. M. Leesnitzer, J. B. Stimmel, T. M. Willson, et al.
The Novel Synthetic Triterpenoid, CDDO-Imidazolide, Inhibits Inflammatory Response and Tumor Growth in Vivo
Clin. Cancer Res., July 1, 2003; 9(7): 2798 - 2806.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.